ScripsAmerica Inc. (SCRCQ)

[coolerheadsprevail]

LOL, the "gut"-less CORE criminal speakeths!!!

the corporate update clearly stated future revenues will come from specialty pharmacy. Enough said.

Well, then, why would a CORE member post a link to the SeeThruEquity "analyst" report that touted a price target of $1.20 -- especially when STE stated that the price target was based on SCRC's declarations that RapiMed would launch in Hong Kong by Q4'14, in mainland China by Q1'15, and several other international markets by the end of 2015?

Only CORE criminals have the forked tongues necessary to simultaneously talk out of both sides of their mouths like this...